S-1
EX-FILING FEES
0002079272
N/A
N/A
0002079272
1
2026-09-16
2026-09-16
0002079272
2026-09-16
2026-09-16
iso4217:USD
xbrli:pure
xbrli:shares
Ex-Filing Fees
CALCULATION OF FILING FEE TABLES
S-1
Lakewood-Amedex Biotherapeutics Inc.
Table 1: Newly Registered and Carry Forward Securities
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Line Item Type |
|
Security Type |
|
Security Class Title |
|
Notes |
|
Fee Calculation
Rule |
|
Amount Registered |
|
Proposed Maximum Offering
Price Per Unit |
|
Maximum Aggregate Offering Price |
|
Fee Rate |
|
Amount of Registration Fee |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Newly Registered Securities |
| Fees to be Paid |
|
Equity |
|
Common stock, par value $0.0001 per share |
|
(1) |
|
Other |
|
4,512,400 |
|
$ |
1.95 |
|
$ |
8,799,180.00 |
|
0.0001381 |
|
$ |
1,215.17 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Offering Amounts: |
|
$ |
8,799,180.00 |
|
|
|
|
1,215.17 |
| Total Fees Previously Paid: |
|
|
|
|
|
|
|
0.00 |
| Total Fee Offsets: |
|
|
|
|
|
|
|
0.00 |
| Net Fee Due: |
|
|
|
|
|
|
$ |
1,215.17 |
__________________________________________
Offering Note(s)
| (1) | |
Estimated in accordance with Rule 457(c) solely for purposes of calculating the registration fee. The maximum price per security and the maximum aggregate offering price are based on the average of the high ($2.05) and low ($1.84) sale price of a common share as reported on The Nasdaq Stock Market LLC on September 17, 2026, which date is within five business days prior to filing this registration statement. |